Simple drug may shield preterm babies from brain damage
NCT ID NCT07524972
First seen Apr 20, 2026 · Last updated May 25, 2026 · Updated 1 time
Summary
This study tests whether giving magnesium sulphate to pregnant women at high risk of early delivery can lower the chance of their baby developing cerebral palsy. About 138 women between 32 and 35 weeks of pregnancy will receive either the drug or a placebo before birth. Researchers will then check the babies' brain development over time to see if the treatment helps prevent serious complications.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CEREBRAL PALSY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Suez Canal University
RECRUITINGIsmailia, Ismailia Governorate, 8366004, Egypt
Contact
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.